Imeglimin

Imeglimin
Names

IUPAC name (2S)-N⁶,N⁶,2-Trimethyl-1,2-dihydro-1,3,5-triazine-4,6-diamine
Identifiers
CAS Number	775351-65-0
3D model (Jmol)	Interactive image
ChemSpider	26232690
InChI InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1 Key: GFICWFZTBXUVIG-SCSAIBSYSA-N InChI=1/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1 Key: GFICWFZTBXUVIG-SCSAIBSYBC
SMILES C[C@H]1NC(=NC(=N1)N)N(C)C
Properties
Chemical formula	C₆H₁₃N₅
Molar mass	155.21 g·mol⁻¹
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Imeglimin is an experimental drug being developed as an oral anti-diabetic. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. It will be the first of a new class of anti-diabetic if it is approved.

References

This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.